Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinically validated XR therapeutic applications for rehabilitation and mental health. Based in Boston, MA.
XRHealth is a digital therapeutics company headquartered in Boston, Massachusetts, that develops clinically validated extended reality (XR) applications for medical rehabilitation and mental health treatment. Founded in 2016, XRHealth holds FDA 510(k) clearances for several of its XR therapeutic applications, a distinction that separates it from general wellness VR products and enables its applications to be prescribed by licensed clinicians and billed through health insurance. The company's platform spans rehabilitation for neurological conditions (stroke recovery, traumatic brain injury, Parkinson's disease), musculoskeletal rehabilitation, and cognitive and mental health interventions, all delivered through consumer-grade VR headsets in clinical settings or the patient's home.\n\nXRHealth's platform combines therapeutic XR applications with a clinical intelligence layer that captures patient performance data during each session—motion range, reaction time, cognitive accuracy, and engagement metrics—and presents it through a clinician portal for remote monitoring and treatment plan adjustment. This telehealth-integrated model enables physical therapists, occupational therapists, and neurologists to prescribe XR therapy programs and monitor patient progress asynchronously, extending the reach of rehabilitation services beyond clinic walls. The company partners with hospital systems, rehabilitation centers, and insurance providers to integrate XR therapy into standard care pathways.\n\nXRHealth competes with AppliedVR, Penumbra's REAL System, and MindMaze in the clinical XR therapeutics market. Its FDA-cleared product portfolio, insurance reimbursement progress, and clinician-facing data platform distinguish it from consumer wellness VR tools and position it as a credentialed medical technology company. For healthcare providers and payers seeking technology-enabled rehabilitation solutions that can demonstrate clinical outcomes and integrate into existing care management workflows, XRHealth offers one of the most clinically validated XR therapy platforms commercially available.
FY2025 (ended Mar 31, 2025): JPY 21.6887T (+6.2%) | Operating Profit: JPY 1.2134T (-12.2%) | FY2024: JPY 20.4286T (+20.8%) | Q3 FY2024 (9 months): Op Profit JPY 1.1399T, margin 7.0% | Auto sales down 297k (Asia impact) | FY2026 guidance: Net profit JPY 250B (-70.1%), Revenue JPY 20.3T (-6.4%)
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded into automobiles, power equipment, marine engines, and aerospace, becoming one of the largest and most diversified mobility companies in the world. With over 90 million vehicles sold globally and a reputation built on engineering reliability, fuel efficiency, and innovation, Honda operates manufacturing facilities across more than 30 countries on six continents.\n\nHonda's automotive lineup ranges from mass-market sedans and SUVs — including the best-selling Civic and CR-V — to trucks, minivans, and the premium Acura brand. The company is executing a major pivot to electrification through the Honda 0 Series, a new EV architecture designed from the ground up for battery-electric vehicles launching in 2026. Honda's partnership with General Motors on battery technology, combined with its investment in solid-state battery development, reflects a multi-path electrification strategy designed to hedge technology risk while building scale.\n\nHonda reported FY2025 revenue of JPY 21.7 trillion, a 6.2% year-over-year increase, driven by strong North American demand and favorable currency tailwinds. The company faces intensifying competition from Chinese EV manufacturers in Asia and is exploring a potential merger with Nissan as part of broader Japanese automotive consolidation. Honda's engineering culture, global manufacturing scale, and brand credibility in reliability position it as a resilient and well-capitalized incumbent navigating the EV transition.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.